Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery
- PMID: 16677756
- PMCID: PMC2734268
- DOI: 10.1016/j.canlet.2006.03.029
Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery
Abstract
Preventing peritoneal implantation of ovarian carcinoma cells could prolong patient remission and survival. CA125 is expressed on most ovarian cancer cells and was reported to be a ligand of mesothelin, a peritoneal protein. We developed a cell adhesion assay with CA125-expresser ovarian cancer cells and human mesothelin-transfected cells and we confirmed that CA125 and mesothelin mediate cell attachment. We also showed that this assay supplies a high-throughput screening system for reagents able to block CA125/mesothelin-dependent cell attachment with a sensitive quantitative readout. We finally demonstrated that a mesothelin chimeric protein and anti-CA125 antibodies block CA125/mesothelin-dependent cell attachment.
Figures




Similar articles
-
Development and in vitro validation of anti-mesothelin biobodies that prevent CA125/Mesothelin-dependent cell attachment.Cancer Lett. 2007 Oct 8;255(2):263-74. doi: 10.1016/j.canlet.2007.04.012. Epub 2007 Jun 7. Cancer Lett. 2007. PMID: 17560019
-
A binding domain on mesothelin for CA125/MUC16.J Biol Chem. 2009 Feb 6;284(6):3739-49. doi: 10.1074/jbc.M806776200. Epub 2008 Dec 15. J Biol Chem. 2009. PMID: 19075018 Free PMC article.
-
Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion.J Biol Chem. 2004 Mar 5;279(10):9190-8. doi: 10.1074/jbc.M312372200. Epub 2003 Dec 15. J Biol Chem. 2004. PMID: 14676194
-
Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment.Expert Rev Anticancer Ther. 2018 Feb;18(2):177-186. doi: 10.1080/14737140.2018.1418326. Epub 2017 Dec 21. Expert Rev Anticancer Ther. 2018. PMID: 29241375 Review.
-
[Tumor Marker CA125: biochemical and molecular properties].Bull Cancer. 2009 May;96(5):597-601. doi: 10.1684/bdc.2009.0859. Epub 2009 May 12. Bull Cancer. 2009. PMID: 19435686 Review. French.
Cited by
-
Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3.BMC Cancer. 2014 Jan 21;14:35. doi: 10.1186/1471-2407-14-35. BMC Cancer. 2014. PMID: 24447304 Free PMC article.
-
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125.Gynecol Oncol. 2012 Apr;125(1):65-9. doi: 10.1016/j.ygyno.2011.11.050. Epub 2011 Dec 7. Gynecol Oncol. 2012. PMID: 22155417 Free PMC article. Clinical Trial.
-
Mannose receptor (MR) engagement by mesothelin GPI anchor polarizes tumor-associated macrophages and is blocked by anti-MR human recombinant antibody.PLoS One. 2011;6(12):e28386. doi: 10.1371/journal.pone.0028386. Epub 2011 Dec 6. PLoS One. 2011. PMID: 22163010 Free PMC article.
-
Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells.Oncogene. 2010 May 20;29(20):2893-904. doi: 10.1038/onc.2010.87. Epub 2010 Mar 29. Oncogene. 2010. PMID: 20348949 Free PMC article. Review.
-
Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.Mol Cancer. 2006 Oct 26;5(1):50. doi: 10.1186/1476-4598-5-50. Mol Cancer. 2006. PMID: 17067392 Free PMC article.
References
-
- Rump A, Morikawa Y, Tanaka M, Minami S, Umesaki N, Takeuchi M, et al. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion. J Biol Chem. 2004;279(10):9190–9198. - PubMed
-
- Yamaguchi N, Yamamura Y, Konishi E, Ueda K, Kojima T, Hattori K, et al. Characterization, molecular cloning and expression of megakaryocyte potentiating factor. Stem Cells. 1996;14(Suppl 1):62–74. - PubMed
-
- Kojima T, Oheda M, Hattori K, Taniguchi Y, Tamura M, Ochi N, et al. Molecular cloning and expression of megakaryocyte potentiating factor cDNA. J Biol Chem. 1995;270(37):21984–21990. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous